Genmab AS

NAS:GMABHealthcareNASDAQ:NBInasdaq_composite

$38.50+4.05%At closeAt close · Tue 20 Oct · ≈ AED 141.39 · Market cap $22.43B · Next earnings Thu 5 Nov · Extended $38.52 +0.04%

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	100.0%	100.0%	100.0%	98.6%	95.4%	91.7%	—	—
Operating margin	62.4%	35.1%	43.2%	32.3%	31.1%	33.6%	33.6%	+0.0 pts
Net margin	47.1%	35.1%	37.6%	26.4%	36.4%	25.9%	25.9%	+0.0 pts
EBITDA margin	60.9%	49.7%	50.6%	36.1%	45.0%	35.9%	—	—
Return on equity	24.9%	13.3%	20.0%	13.8%	21.4%	16.5%	16.5%	+0.0 pts
Return on assets	22.5%	12.0%	18.1%	12.3%	17.1%	7.5%	7.5%	+0.0 pts
Return on capital employed	31.7%	12.8%	22.1%	16.2%	16.5%	11.0%	—	—
Debt / equity	0.0×	0.0×	0.0×	0.0×	0.0×	0.9×	0.9×	+0.0%
Debt / assets	1.5%	1.7%	2.0%	2.2%	2.2%	42.2%	—	—
Interest coverage	631.3×	227.2×	298.4×	197.1×	55.9×	20.5×	—	—
Current ratio	15.0×	14.5×	15.5×	13.3×	5.2×	2.0×	2.0×	+0.0%
Quick ratio	15.0×	14.5×	15.5×	13.3×	5.2×	2.0×	—	—
Cash ratio	5.8×	5.7×	5.4×	6.0×	1.9×	1.2×	1.2×	+0.0%
Asset turnover	0.5×	0.3×	0.5×	0.5×	0.5×	0.3×	—	—
Inventory turnover	—	—	—	4.0×	15.9×	17.2×	—	—
Receivables turnover	4.1×	2.5×	2.5×	3.3×	3.2×	3.2×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—